Dr. Pauline M. Camacho

• 
  www.greenwichbiotech.com/ja/news/read-article.html?arti - [Cached Version]
  Published on: 9/16/2009    Last Visited: 10/4/2009  

  The study by Dr. Pauline Camacho and colleagues was presented at the annual meeting of the American Society for Bone and Mineral Research.
  
  "Doctors evaluating breast cancer patients for possible bone loss should look further than cancer drugs," Camacho said.
  ...
  Camacho and colleagues reviewed charts of 81 consecutive breast cancer patients who were referred to Loyola's Osteoporosis and Metabolic Bone Disease Center for treatment or prevention of osteoporosis.
  ...
  Camacho said the study demonstrates that bone loss "can be prevented in women undergoing hormonal therapy if secondary causes of bone loss are corrected and bisphosphonate osteoporosis drugs are appropriately used. Camacho is an associate professor of medicine at Loyola University Chicago Stritch School of Medicine and director of Loyola's Osteoporosis and Metabolic Bone Disease Center.

• 
  www.loyolamedicine.com/News/News_Releases/index.cfm?ren - [Cached Version]
  Last Visited: 7/6/2009  

  MAYWOOD, Il. -- Loyola University Health System endocrinologist Dr. Pauline Camacho is co-editor of one of the most widely read books in endocrinology, which recently came out in its second edition...

• 
  www.ibdnews.com/2006/01/loyola-to-study-for-first-time- - [Cached Version]
  Published on: 1/10/2006    Last Visited: 7/10/2007  

  'We want to give patients a more convenient treatment option to enhance compliance and to avoid common complications like fractures,' said Dr. Pauline Camacho, principal investigator of the study and director of the Osteoporosis and Metabolic Bone Disease Center at Loyola.

• 
  ahorn.aace.com/org/committees.php?comm=ENTSC - [Cached Version]
  Published on: 8/10/2007    Last Visited: 8/10/2007  

  Pauline M. Camacho, MD, FACE
  
  Loyola Univ Medical Ctr, Div of Endo2160 S 1st AveMaywood, IL 60153-3304Phone: (708) 216-0436Fax: (708) 216-5936

• 
  www.kcendt.com/?p=17025 - [Cached Version]
  Last Visited: 9/28/2009  

  Study leader Pauline Camacho, associate professor of medicine at Loyola University Chicago Stritch School of Medicine and director of Loyola's Osteoporosis and Metabolic Bone Disease Center, was quoted as saying, "Doctors evaluating breast cancer patients for possible bone loss should look further than cancer drugs."
  ...
  Camacho and colleagues reviewed charts of 81 breast cancer patients who were referred to Loyola's Osteoporosis and Metabolic Bone Disease Center for treatment or prevention of osteoporosis.
  ...
  Camacho said the study demonstrates that bone loss "can be prevented in women undergoing hormonal therapy if secondary causes of bone loss are corrected and bisphosphonate osteoporosis drugs are appropriately used."

• 
  www.bcam.qc.ca/news/16-1/newsbriefs161.html - [Cached Version]
  Published on: 9/1/2007    Last Visited: 1/26/2008  

  The report was the work of Dr. Pauline M. Camacho and colleagues at Loyola University of Chicago.
  
  Cognitive function and chemotherapy.

• 
  www.eurekalert.org/pub_releases/2008-11/luhs-sic111908. - [Cached Version]
  Published on: 11/19/2008    Last Visited: 11/20/2008  

  "Doctors evaluating breast cancer patients for possible bone loss should look further than cancer drugs," said Dr. Pauline Camacho, lead author of the study in the Journal of Clinical Oncology. Camacho is an associate professor in the department of medicine, division of endocrinology and metabolism, Loyola University Chicago Stritch School of Medicine.
  ...
  Excessive calcium excretion can be treated with a "water pill" that's also used to treat high blood pressure, Camacho said. There are various treatments for parathyroid gland disorder, depending on its cause.
  
  In certain breast cancer patients, bone loss from cancer drugs can be treated with osteoporosis drugs such as alendronate sodium (Fosamax) and ibandronate sodium (Boniva), Camacho said.
  ...
  Albain referred O'Connor to Camacho, who prescribed calcium supplements, prescription vitamin D and the osteoporosis drug Boniva.

• 
  aace.tekgroup.com/article_display.cfm?article_id=4863 - [Cached Version]
  Published on: 11/11/2008    Last Visited: 5/19/2009  

  Pauline M. Camacho, MD, FACE
  
  Join AACE Contact Us AACE Online Copyright and Privacy Policy

• 
  ahorn.aace.com/org/committees.php?comm=INTL - [Cached Version]
  Published on: 8/10/2007    Last Visited: 8/10/2007  

  Pauline M. Camacho, MD, FACE
  
  Loyola Univ Medical Ctr, Div of Endo2160 S 1st AveMaywood, IL 60153-3304Phone: (708) 216-0436Fax: (708) 216-5936
  
  Mihail Gr.Coculescu, MD, PhD, FRCP, FACE

• 
  AACE Newsroom: Faramarz Ismail-Beigi, MD, PhD - [Cached Version]
  Published on: 5/29/2008    Last Visited: 12/20/2008  

  Pauline M. Camacho, MD, FACE

Page:  1 2 3 4